全文获取类型
收费全文 | 39978篇 |
免费 | 4404篇 |
国内免费 | 2941篇 |
专业分类
耳鼻咽喉 | 367篇 |
儿科学 | 720篇 |
妇产科学 | 433篇 |
基础医学 | 3912篇 |
口腔科学 | 894篇 |
临床医学 | 5377篇 |
内科学 | 5060篇 |
皮肤病学 | 378篇 |
神经病学 | 1499篇 |
特种医学 | 1352篇 |
外国民族医学 | 10篇 |
外科学 | 3275篇 |
综合类 | 8568篇 |
现状与发展 | 11篇 |
一般理论 | 1篇 |
预防医学 | 3752篇 |
眼科学 | 1084篇 |
药学 | 4701篇 |
57篇 | |
中国医学 | 2860篇 |
肿瘤学 | 3012篇 |
出版年
2024年 | 220篇 |
2023年 | 780篇 |
2022年 | 2062篇 |
2021年 | 2470篇 |
2020年 | 2087篇 |
2019年 | 1386篇 |
2018年 | 1436篇 |
2017年 | 1437篇 |
2016年 | 1298篇 |
2015年 | 2084篇 |
2014年 | 2451篇 |
2013年 | 2421篇 |
2012年 | 3411篇 |
2011年 | 3496篇 |
2010年 | 2478篇 |
2009年 | 1993篇 |
2008年 | 2168篇 |
2007年 | 2118篇 |
2006年 | 1995篇 |
2005年 | 1801篇 |
2004年 | 1142篇 |
2003年 | 1029篇 |
2002年 | 793篇 |
2001年 | 675篇 |
2000年 | 648篇 |
1999年 | 686篇 |
1998年 | 399篇 |
1997年 | 409篇 |
1996年 | 291篇 |
1995年 | 308篇 |
1994年 | 232篇 |
1993年 | 140篇 |
1992年 | 155篇 |
1991年 | 177篇 |
1990年 | 137篇 |
1989年 | 120篇 |
1988年 | 84篇 |
1987年 | 86篇 |
1986年 | 72篇 |
1985年 | 45篇 |
1984年 | 31篇 |
1983年 | 21篇 |
1982年 | 19篇 |
1981年 | 10篇 |
1980年 | 8篇 |
1979年 | 13篇 |
1978年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
目的:介绍一种可调式外固定器,用于髌骨骨折的固定,可以早期功能锻炼。方法:既可开放复位穿针外固定,也可在透视下闭合穿针外固定。结果:本组50例,优28例,良20例,差2例。结论:该固定器操作简单,损伤小,免除第二次手术取固定器,是髌骨骨折外固定较佳器械。 相似文献
82.
83.
髌骨关节面的应用解剖学研究 总被引:2,自引:0,他引:2
本文利用150例髌骨(干燥髌骨100例,福尔马林固定膝关节内的髌骨50例)观测了髌骨关节面和关节软骨的形态及其与股骨内外侧髁关节面在屈膝0~135度范围的对应关系。结果发现中间纵嵴向后突起并由下向上逐渐变凸占100%;内侧纵嵴明显突起者占62%,此时其髌骨内侧部关节面与股骨关节面之间的间隙较大;在膝关节屈曲过程申两关节面接触的顺序为髌骨关节面自下而上、股骨内外侧关节面从前向后相对滑动,伸膝时则相反;髌骨关节面的表面积为1019±20(650~1540)mm~2。并讨论了髌骨关节面的解剖学特点及其临床意义。 相似文献
84.
85.
目的:观察Agilent2100 Bioanalyzer芯片分析系统(以下简称Bioanalyzer)在基因差异表达研究中的应用。方法:应用限制性显示技术分别从正常和热休克处理后的酿酒酵母细胞中分离出cDNA片段,然后再用Bioanalyzer和传统的琼脂糖凝胶电泳技术对RD-PCR产物进行检测分析。结果:Bioanalyzer能更快速、敏感地分离和显示差异表达的基因片段,并且通过对差异片段进行定量比较,发现了数个表达有明显差异的基因片段。结论:Bioanalyzer在基因差异表达研究中具有重要的应用价值。 相似文献
86.
陈潜 《中国医学文摘:外科学分册英文版》2007,16(2):141-142
Objective To compare the clinical efficacy and complications of transurethral resection of the prostate (TURP),transurethral vapor-resection of the prostate (TUVP) and plasmakinetic energy transurethral resection of the prostate (PKRP) for benign prostatic hypertrophy (BPH).Methods A total of 545 patients with BPH were enrolled from December 1999 to Januare 2004. 相似文献
87.
A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart. 总被引:2,自引:0,他引:2
Cheng Qian René A Tio Anton J M Roks Kristien M Boddeus Martin C Harmsen Wiek H van Gilst Regien G Schoemaker 《Cardiovascular pathology》2007,16(3):127-135
OBJECTIVE: To investigate the feasibility of intracoronary application of endothelial progenitor cells and the subsequent distribution within the heart. METHODS: Endothelial progenitors cells (EPCs) cultured from rat bone marrow were identified by double-positive staining with Dil-Ac-LDL and BS1-lectin. Twenty-four hours before cell transplantation, EPCs were labeled with 5-bromo-2'-deoxyuridine (BrdU). Cells (5 x 10(5) in 250-microl medium) were injected into healthy rats, either as intracoronary application (n=11) or as intramyocardial injection (n = 6). At 15 min or 3 days posttransplantation, hearts as well as other organs (lung, liver, kidney, and spleen) were collected and processed for subsequent BrdU immunohistochemistry. The number of BrdU-positive cells per tissue area was counted. RESULTS: Compared to intramyocardial injection, intracoronary administration resulted in more than twice as much positive cells in the heart (P < .05), with no local differences within the heart. Whereas after 15 min, EPCs were equally distributed in all examined organs (except for the spleen), cells that were still present after 3 days, approximately 10%, were selectively restricted to the heart. CONCLUSIONS: Our data indicate that the intracoronary application provides a promising technique for EPC transplantation in the rat heart. 相似文献
88.
以硫酸二乙酯(DES)诱变处理黄色短杆菌(Brevibacteriumflavum)XQ5122,得到突变株V3-36<Leu ̄1、α-AB ̄r、AHV ̄r),在10%葡萄糖培养基中可积累2.3%L-缬氨酸。以亚硝基胍(NTG)诱变V4-153,得到一株突变株(Leu ̄1、α-AB ̄r、AHV ̄r、2-TA ̄r),再进行单菌落分离,得到突变株ZQ-2,能在培养基中积累L-缬氨酸4.2%~4.5%,最高达5.57%. 相似文献
89.
Allen Cato III Linda E. Gustavson Jiang Qian Tawakol El-Shourbagy Edward A. Kelly 《Epilepsia》1998,39(1):43-47
Summary: Purpose: We wished to determine the effect of renal impairment on the pharmacokinetics and tolerability of the new antiepileptic drug tiagabine (TGB).
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
90.
Interaction of native proteinaceous antigens during the recognition and the effector phases of an immune response leads to antigenic conformational modifications which may elicit additional specific immune response. Protein cross-linking and conformation restraining formaldehyde and glutaraldehyde have been extensively used in vaccine preparation, but the relative efficiencies of conformational restraint at concentrations similar to those used in vaccine preparation have not been investigated. We addressed this issue by comparing the extent of conformational restraint of virus proteins in formaldehyde- and glutaraldehyde-treated virus preparations by monitoring the fluorescence intensities (I320) of infectious bursal disease virus preparations (IBDV) and those of untreated virus during thermal denaturation. Formaldehyde was found to cause no detectable conformational restraint at 0.01% and only very weak restraint at 1%, while glutaraldehyde caused very strong conformational restraint at 0.01%. It is proposed how conformational restraint of proteinaceous antigens may alter ensuing immunity. 相似文献